{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:01:05Z","timestamp":1781640065486,"version":"3.54.5"},"reference-count":46,"publisher":"Norwegian Medical Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2016,2,23]]},"DOI":"10.4045\/tidsskr.15.0451","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T08:36:54Z","timestamp":1456303014000},"page":"317-21","source":"Crossref","is-referenced-by-count":6,"title":["Bruk av antibiotika i svangerskapet"],"prefix":"10.4045","volume":"136","author":[{"given":"Stina","family":"Nordeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"H\u00f8ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Engeland A, Bramness JG, Daltveit AK et al. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004\u2009\u2013\u20092006. Br J Clin Pharmacol 2008; 65: 653\u2009\u2013\u200960. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18294334&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-2125.2008.03102.x","DOI":"10.1111\/j.1365-2125.2008.03102.x"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"McIntyre J, Choonara I. Drug toxicity in the neonate. Biol Neonate 2004; 86: 218\u2009\u2013\u200921. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15249753&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1159\/000079656","DOI":"10.1159\/000079656"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006; 107: 1120\u2009\u2013\u200938. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16648419&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/01.AOG.0000216197.26783.b5","DOI":"10.1097\/01.AOG.0000216197.26783.b5"},{"key":"ref=4","unstructured":"Helsedirektoratet. Nasjonale faglige retningslinjer for antibiotikabruk i\u00a0prim\u00e6rhelsetjenesten. 2015. www.antibiotikaiallmennpraksis.no (21.12.2015)."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"B\u00e9rard A, Sheehy O, Zhao JP et al. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. Pharmacoepidemiol Drug Saf 2015; 24: 1241\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26513406&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/pds.3900","DOI":"10.1002\/pds.3900"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Padberg S, Wacker E, Meister R et al. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones. Antimicrob Agents Chemother 2014; 58: 4392\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24841264&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1128\/AAC.02413-14","DOI":"10.1128\/AAC.02413-14"},{"key":"ref=7","unstructured":"Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 2009; 3: e123\u2009\u2013\u200930. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21603045&dopt=Abstract"},{"key":"ref=8","unstructured":"Nasjonalt kunnskapssenter for helsetjenesten. Sjekklister for vurdering av forskningsartikler. www.kunnskapssenteret.no\/verktoy\/sjekklister-for-vurdering-av-forskningsartikler (12.2.2015)."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Andersen JT, Petersen M, Jimenez-Solem E et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS ONE 2013; 8: e53327. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23301061&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1371\/journal.pone.0053327","DOI":"10.1371\/journal.pone.0053327"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"K\u00e4ll\u00e9n B, Danielsson BR. Fetal safety of erythromycin. An update of Swedish data. Eur J Clin Pharmacol 2014; 70: 355\u2009\u2013\u200960. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24352632&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00228-013-1624-3","DOI":"10.1007\/s00228-013-1624-3"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Lund M, Pasternak B, Davidsen RB et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ 2014; 348: g1908.","DOI":"10.1136\/bmj.g1908"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Rom\u00f8ren M, Lindb\u00e6k M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin \u2013 a population-based register study from Norway. Br J Clin Pharmacol 2012; 74: 1053\u2009\u2013\u200962. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22463376&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-2125.2012.04286.x","DOI":"10.1111\/j.1365-2125.2012.04286.x"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Bahat Dinur A, Koren G, Matok I\u00a0et al. Fetal safety of macrolides. Antimicrob Agents Chemother 2013; 57: 3307\u2009\u2013\u200911. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23650169&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1128\/AAC.01691-12","DOI":"10.1128\/AAC.01691-12"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Bar-Oz B, Diav-Citrin O, Shechtman S et al. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study. Eur J Obstet Gynecol Reprod Biol 2008; 141: 31\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18760873&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ejogrb.2008.07.008","DOI":"10.1016\/j.ejogrb.2008.07.008"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Bar-Oz B, Weber-Schoendorfer C, Berlin M et al. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug Saf 2012; 35: 589\u2009\u2013\u200998. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22702640&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/11630920-000000000-00000","DOI":"10.2165\/11630920-000000000-00000"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Lin KJ, Mitchell AA, Yau WP et al. Safety of macrolides during pregnancy. Am J Obstet Gynecol 2013; 208: 221.e1\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23254249&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ajog.2012.12.023","DOI":"10.1016\/j.ajog.2012.12.023"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Sarkar M, Woodland C, Koren G et al. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16734900&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186\/1471-2393-6-18","DOI":"10.1186\/1471-2393-6-18"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Lin KJ, Mitchell AA, Yau WP et al. Maternal exposure to amoxicillin and the risk of oral clefts. Epidemiology 2012; 23: 699\u2009\u2013\u2009705. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22766750&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/EDE.0b013e318258cb05","DOI":"10.1097\/EDE.0b013e318258cb05"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Puh\u00f3 EH, Szunyogh M, M\u00e9tneki J et al. Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J 2007; 44: 194\u2009\u2013\u2009202. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17328645&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1597\/05-208.1","DOI":"10.1597\/05-208.1"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"M\u00f8lgaard-Nielsen D, Hviid A. Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study. Pharmacoepidemiol Drug Saf 2012; 21: 246\u2009\u2013\u200953. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22125260&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/pds.2179","DOI":"10.1002\/pds.2179"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Andersen JT, Petersen M, Jimenez-Solem E et al. Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study. Epidemiol Infect 2013; 141: 1749\u2009\u2013\u200955. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23010291&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1017\/S0950268812002178","DOI":"10.1017\/S0950268812002178"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Yang J, Xie RH, Krewski D et al. Exposure to trimethoprim\/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. Int J Infect Dis 2011; 15: e336\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21345707&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ijid.2011.01.007","DOI":"10.1016\/j.ijid.2011.01.007"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Goldberg O, Koren G, Landau D et al. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations. J Clin Pharmacol 2013; 53: 991\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23873250&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/jcph.139","DOI":"10.1002\/jcph.139"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Nordeng H, Lupattelli A, Rom\u00f8ren M et al. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 2013; 121: 306\u2009\u2013\u200913. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23344280&dopt=Abstract","DOI":"10.1097\/AOG.0b013e31827c5f88"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Crider KS, Cleves MA, Reefhuis J et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009; 163: 978\u2009\u2013\u200985. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19884587&dopt=Abstract","DOI":"10.1001\/archpediatrics.2009.188"},{"key":"ref=26","unstructured":"Eri\u0107 M, Sabo A. Teratogenicity of antibacterial agents. Coll Antropol 2008; 32: 919\u2009\u2013\u200925. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18982771&dopt=Abstract"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009; 23: 18\u2009\u2013\u200928. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19228311&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-3016.2008.00978.x","DOI":"10.1111\/j.1365-3016.2008.00978.x"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Santos F, Sheehy O, Perreault S et al. Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study. BJOG 2011; 118: 1374\u2009\u2013\u200982. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21749628&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1471-0528.2011.03041.x","DOI":"10.1111\/j.1471-0528.2011.03041.x"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"N\u00f8rgaard M, Skriver MV, S\u00f8rensen HT et al. Risk of miscarriage for pregnant users of pivmecillinam: a population-based case-control study. APMIS 2008; 116: 278\u2009\u2013\u200983. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18397462&dopt=Abstract","DOI":"10.1034\/j.1600-0463.2003.11101031.x-i1"},{"key":"ref=30","unstructured":"EUROCAT guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomialies. Antrim: EUROCAT Central Registry, 2005. www.eurocat-network.eu\/aboutus\/datacollection\/guidelinesforregistration\/guide1_3instructionmanual (21.12.2015)."},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011; 283: 7\u2009\u2013\u200918. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20814687&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00404-010-1646-3","DOI":"10.1007\/s00404-010-1646-3"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010; 686: 349\u2009\u2013\u200964. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20824455&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/978-90-481-9485-8_20","DOI":"10.1007\/978-90-481-9485-8_20"},{"key":"ref=33","unstructured":"DSS Research. Calculators. www.dssresearch.com\/KnowledgeCenter\/toolkitcalculators\/statisticalpowercalculators.aspx (19.12.2014)."},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Shepard TH. \u00abProof\u00bb of human teratogenicity. Teratology 1994; 50: 97\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7801306&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/tera.1420500202","DOI":"10.1002\/tera.1420500202"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"K\u00e4ll\u00e9n BA, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209\u2009\u2013\u200914. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15907655&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.reprotox.2005.01.010","DOI":"10.1016\/j.reprotox.2005.01.010"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Nilsson MF, Webster WS. Effects of macrolide antibiotics on rat embryonic heart function in vitro. Birth Defects Res B Dev Reprod Toxicol 2014; 101: 189\u2009\u2013\u200998. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24753334&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/bdrb.21107","DOI":"10.1002\/bdrb.21107"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997; 89: 524\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9083306&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0029-7844(97)00005-7","DOI":"10.1016\/S0029-7844(97)00005-7"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Rockenbauer M, S\u00f8rensen HT et al. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001; 15: 637\u2009\u2013\u200946. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11738517&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0890-6238(01)00178-2","DOI":"10.1016\/S0890-6238(01)00178-2"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Larsen H, Nielsen GL, M\u00f8ller M et al. Birth outcome and risk of neonatal hypoglycaemia following in utero exposure to pivmecillinam: a population-based cohort study with 414 exposed pregnancies. Scand J Infect Dis 2001; 33: 439\u2009\u2013\u200944. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11450863&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/00365540152029909","DOI":"10.1080\/00365540152029909"},{"key":"ref=40","unstructured":"Schaefer C, Peters P, Miller RK. Drugs during pregnancy and lactation. 3. utg. Amsterdam: Elsevier, 2014."},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Nordeng H, Ystr\u00f8m E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010; 66: 207\u2009\u2013\u200914. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19841915&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00228-009-0744-2","DOI":"10.1007\/s00228-009-0744-2"},{"key":"ref=42","unstructured":"Larson L, Powrie R, File TM. Treatment of respiratory infections in pregnant women. www.uptodate.com\/contents\/treatment-of-respiratory-infections-in-pregnant-women (3.12.2014)."},{"key":"ref=43","unstructured":"Marrazzo J. Treatment of Chlamydia trachomatis infection. www.uptodate.com\/contents\/treatment-of-chlamydia-trachomatis-infection#H49 (3.12.2014)."},{"key":"ref=44","unstructured":"Patel BN, Lee UJ, Goldman HB. Urinary tract infections in women. London: BMJ Best Practice, 2013. http:\/\/bestpractice.bmj.com\/best-practice\/monograph\/77.html (21.12.2015)."},{"key":"ref=45","doi-asserted-by":"crossref","unstructured":"Stensballe LG, Simonsen J, Jensen SM et al. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013; 162: 832\u2009\u2013\u2009838.e3. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23140881&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.jpeds.2012.09.049","DOI":"10.1016\/j.jpeds.2012.09.049"},{"key":"ref=46","doi-asserted-by":"crossref","unstructured":"N\u00f8rgaard M, Ehrenstein V, Nielsen RB et al. Maternal use of antibiotics, hospitalisation for infection during pregnancy, and risk of childhood epilepsy: a population-based cohort study. PLoS ONE 2012; 7: e30850. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22295115&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1371\/journal.pone.0030850","DOI":"10.1371\/journal.pone.0030850"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:46:55Z","timestamp":1781639215000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/02\/oversiktsartikkel\/bruk-av-antibiotika-i-svangerskapet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2,23]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.15.0451","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}